URGN
UroGen Pharma Ltd.
$17.95
-$0.92(-4.88%)
62
Overall
--
Value
75
Tech
50
Quality
Market Cap
$835.99M
Volume
1.11M
52W Range
$3.42 - $21.71
Target Price
$35.22
EPS Estimates Overview
| Current Quarter | $-0.66 | Next Quarter | $-0.62 |
| Current Year | $-3.06 | Next Year | $-1.09 |
| QoQ Growth | +6.1% | YoY Growth | +64.4% |
| 3Y EPS CAGR | +15.8% | Target Price | $35.22 |
| Consensus | Buy | Upside | +96.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $17.95 | -4.9% | 1.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |